Encouraging 6-year #NATALEE results presented at #ESMO26 ! 🎯

返回会议原文

返回会议

Kristina Jankovic, MD· @JankovicK · X·2026-10-24 01:42· 3 天前评分70

NATALEE

正文 · 原文

Encouraging 6-year #NATALEE results presented at #ESMO26 ! 🎯

Adjuvant ribociclib + NSAI shows a deepening iDFS benefit and favourable OS results in HR+/HER2− early #BreastCancer

@OncoAlert

353 浏览 · 5 赞 · 4 转发 · 0 回复

会议摘要

LBA25按 Proffered paper 1: Breast cancer, early and advanced stage 对上

Adjuvant ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+/HER2− early breast cancer (EBC): NATALEE 6-y overall survival (OS) and efficacy outcomes

https://esmocongress.esmo.org

引用@

Oral abstract #BreastCancer session at #ESMO26: updated data from NATALEE trial simultaneously published in @Annals_Oncology @OncoAlert @myESMO

在 X 查看被引用的帖子

来源：Kristina Jankovic, MD · x.com